NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

Welp, I was bashed pretty intensely when I said that because it's taken so long the journal article, regardless of the publication, would be a non-factor.

But, yet again, it would appear I am right.

We were trading at $0.90 prior to the journal. After astounding results in a major publication, we are trading at $0.94.

Nobody cares about anything but the potential to get to regulatory approval. The results no longer matter, the journal doesn't matter, all of this info was known and baked into the price long ago. The only thing that matters is approvals. A topic the company has failed to provide an update on (other than the fact they haven't submitted any applications) in over two years. It's absolutely mind boggling that they still refuse to issue any sort of update on the approval process.